The Prostate cancer Research International: Active Surveillance study

被引:23
作者
Bangma, Chris H. [1 ]
Bul, Meelan [1 ]
Roobol, Monique [1 ]
机构
[1] Erasmus MC, Dept Urol, Rotterdam, Netherlands
关键词
active surveillance; low-risk cancer; prostate cancer; COMPUTER-AIDED ULTRASONOGRAPHY; MEN; VALIDATION; MORTALITY; NOMOGRAM;
D O I
10.1097/MOU.0b013e328351dcc7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review To inform readers on the ongoing activities of the Prostate cancer Research International: Active Surveillance (PRIAS) study in the light of current findings and research problems on active surveillance worldwide. Recent findings Recent data from the PRIAS study combined with PubMed-based literature from the last 3 years. Summary The PRIAS study is a rapidly growing registry for active surveillance of low-risk prostate cancer. The study is conducted worldwide, facilitated by an electronic Web-based decision tool with password-restricted access for physicians. Inclusion and monitoring is performed according to protocol. Over 2000 men have been included from over 100 participating centres in 17 countries in four continents. The study was initiated in December 2006. Risk reclassification on repeat biopsy during follow-up has occurred in 27% of biopsied men, although a switch towards active therapy has been performed in 22% of the total cohort.
引用
收藏
页码:216 / 221
页数:6
相关论文
共 30 条
[1]   Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer [J].
Braeckman, Johan ;
Autier, Philippe ;
Garbar, Christian ;
Marichal, Miriam Pipeleers ;
Soviany, Cristina ;
Nir, Rina ;
Nir, Dror ;
Michielsen, Dirk ;
Bleiberg, Harry ;
Egevad, Lars ;
Emberton, Mark .
BJU INTERNATIONAL, 2008, 101 (03) :293-298
[2]   The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers [J].
Braeckman, Johan ;
Autier, Philippe ;
Soviany, Cristina ;
Nir, Rina ;
Nir, Dror ;
Michielsen, Dirk ;
Treurnicht, Karien ;
Jarmulowicz, Michael ;
Bleiberg, Harry ;
Govindaraju, Senthil ;
Emberton, Mark .
BJU INTERNATIONAL, 2008, 102 (11) :1560-1565
[3]   Prostate cancer incidence and mortality trends in 37 European countries: An overview [J].
Bray, F. ;
Lortet-Tieulent, J. ;
Ferlay, J. ;
Forman, D. ;
Auvinen, A. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (17) :3040-3052
[4]  
Bul M, 2011, EUR UROL
[5]   MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN SERUM AS A SCREENING-TEST FOR PROSTATE-CANCER [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
DODDS, KM ;
COPLEN, DE ;
YUAN, JJJ ;
PETROS, JA ;
ANDRIOLE, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1156-1161
[6]   PATHOLOGICAL AND CLINICAL FINDINGS TO PREDICT TUMOR EXTENT OF NONPALPABLE (STAGE-T1C) PROSTATE-CANCER [J].
EPSTEIN, JI ;
WALSH, PC ;
CARMICHAEL, M ;
BRENDLER, CB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05) :368-374
[7]   Estimates of cancer incidence and mortality in Europe in 2008 [J].
Ferlay, J. ;
Parkin, D. M. ;
Steliarova-Foucher, E. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) :765-781
[8]  
Fütterer JJ, 2009, EXPERT REV ANTICANC, V9, P923, DOI [10.1586/era.09.63, 10.1586/ERA.09.63]
[9]  
Hoeks C, 2012, ACT SURV LOW RISK PR
[10]   Counseling men with prostate cancer: A nomogram for predicting the presence of small, moderately differentiated, confined tumors [J].
Kattan, MW ;
Eastham, JA ;
Wheeler, TM ;
Maru, N ;
Scardino, PT ;
Erbersdobler, A ;
Graefen, M ;
Huland, H ;
Koh, H ;
Shariat, SF ;
Slawin, KM ;
Ohori, M .
JOURNAL OF UROLOGY, 2003, 170 (05) :1792-1797